Principia Biopharma Inc. (PRNB): IPOs News

Key Facts Surrounding This News Item


  • PRNB had returned 0.00% year-to-date leading up to today’s news, versus a 0.00% return from the benchmark S&P 500 during the same period.

More Info About Principia Biopharma Inc. (PRNB)


Principia Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on developing novel oral therapies for immunology and oncology in the United States. It is developing PRN1008, an inhibitor that is in Phase II clinical trial for the treatment of pemphigus, a chronic skin disease, as well as in Phase II clinical trial for the treatment of immune thrombocytopenic purpura; PRN2246, an inhibitor that is in Phase I clinical trial for the treatment of multiple sclerosis and other central nervous system diseases; PRN1371, a drug candidate, which is in Phase I clinical trial for the treatment of solid tumors; and oral small molecule inhibitors of the immunoproteasome. The company has collaboration agreements with Genzyme Corporation and AbbVie Biotechnology Limited. Principia Biopharma Inc. was founded in 2008 and is based in South San Francisco, California. View our full PRNB ticker page with ratings, news, and more.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: CMG | Chipotle Mexican Grill, Inc. Common Stock News, Ratings, and Charts

Chipotle (CMG) reports earnings, tops expectations

The chain’s stock has soared 63% so far in 2019.
NASDAQ: FB | Facebook, Inc. - Class A Common Stock News, Ratings, and Charts

Facebook (FB) reports Q1 earnings, shares surge

Facebook Inc. shares jumped in late trading Wednesday.
NASDAQ: MSFT | Microsoft Corporation News, Ratings, and Charts

Microsoft (MSFT) reports Q3 earnings, shares move higher

Microsoft reported fiscal Q3 2019 earnings on Wednesday, and the stock jumped 2 percent on better-than-expected revenue.
NYSE: CAT | Caterpillar, Inc. Common Stock News, Ratings, and Charts

Caterpillar (CAT) reports earnings, shares slide

Caterpillar Inc spooked investors for a second straight quarter.
NYSE: TWTR | Twitter, Inc. Common Stock News, Ratings, and Charts

Trump met with Twitter (TWTR) CEO Jack Dorsey at the White House

Trump held a closed-door meeting with Twitter co-founder Jack Dorsey at the White House on Tuesday evening to discuss the social media platform.

Read More Stories


More Principia Biopharma Inc. (PRNB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All PRNB News
Page generated in 1.3899 seconds.